Lecanemab, a closely watched new treatment for Alzheimer’s from Eisai and Biogen, held up to scrutiny in a detailed scientific presentation Tuesday.
News
STAT+: Regeneron’s George Yancopoulos admits some regret, but ‘I don’t apologize’
In some of his first public remarks since getting booed on stage last month over Alzheimer’s drug remarks, Regeneron’s George Yancopoulos acknowledged in an interview he could’ve handled things differently. […]
News
STAT+: Still hoping for looser FDA rules, Regeneron says it will test durable antibody for Covid
SAN FRANCISCO — For months, drugmakers have been pleading with regulators to lower the bar for authorizing antibody drugs for Covid. The virus, they noted, had evolved fast enough to… […]
News
STAT+: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap
New legislation introduced by Sen. Bernie Sanders would prohibit all insulin manufacturers from charging more than $20 per vial. […]
